factor

(redirected from Colony-stimulating factor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to Colony-stimulating factor: Granulocyte colony-stimulating factor, macrophage colony stimulating factor, colony stimulating factor 2

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
References in periodicals archive ?
Granulocyte colony-stimulating factor (GCSF) is an expensive prescription drug administered by intramuscular injection under the care of a physician experienced in using the drug.
Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia.
This leads to enhanced activity of the normal JH1 kinase activity of JAK2, which makes the mutated hematopoietic stern cells hypersensitive to the hematopoietic growth factors thrombopoietin, erythropoietin, insulin-like growth factor-1, stem cell factor, and granulocyte colony-stimulating factor, resulting in trilinear hypermyeloproliferation.
Some grade 2 toxicities were seen at higher doses of recombinant fowlpox granulocyte-macrophage colony-stimulating factor, but there were no significant toxicities (J.
Among the potentially involved cytokines are the interleukins (IL-1, IL-3, IL-6, and IL-8), granulocyte colony-stimulating factor, granulocyte-macrophage colony stimulating factor, and interferon-[gamma].
Macrophage colony-stimulating factor can modulate immune responses and attract dendritic cells in vivo.
In patients with acute leukemia who have undergone HLA haplotype-mismatched stem cell transplantation, the administration of granulocyte colony-stimulating factor (G-CSF) to hasten blood cell reconstitution may have more risks than benefits, according to researchers at the University of Perugia in Italy.
Cells from the grossly enlarged organ were grown in culture and found to produce substances with potentially therapeutic properties -- including a white-blood-cell-stimulating substance now known as granulocyte-macrophage colony-stimulating factor (GM-CSF), which researchers say may prove useful against cancer of AIDS.
Granulocyte colony-stimulating factor (G-CSF) is a naturally occurring hormone that is produced by the body to stimulate the bone marrow to produce neutrophils, a type of white blood cell that helps the immune system fight infection.
This Framework Agreement is for the supply of the Granulocyte Colony-Stimulating Factor (G-CSF) Filgrastim to NHS Scotland.
The recombinant nonglycosylated proteins market is further segmented into insulin, granulocyte colony-stimulating factor (G-CSF), interferons, and human growth hormones; whereas, the recombinant glycosylated proteins market is further segmented into erythropoietin, monoclonal antibodies, and follitropin.
oil (GCO) on the synthesis of collagen, elastin, and glycosaminoglycans (GAG) and in the release of transforming growth factor-beta1 (TGF-beta1) and granulocyte-macrophage colony-stimulating factor (GM-CSF) by human skin fibroblasts.

Full browser ?